Journal of Chromatography A 1997-02-21

Assay of bropirimine in rat plasma by means of robotic solid-phase extraction and high-performance liquid chromatography.

C Y Hsu, R R Walters

Index: J. Chromatogr. A. 762(1-2) , 243-9, (1997)

Full Text: HTML

Abstract

A rapid and simple high-performance liquid chromatography (HPLC) method incorporating automated solid-phase extraction (SPE) is described for the determination of bropirimine, 2-amino-5-bromo-6-phenyl-4(3H)-pyrimidinone, in plasma samples from various species. Using an automated sample processor, plasma samples were loaded onto C18 SPE columns and the drug eluted with ethanol-methylene chloride (10:90, v/v). The extracts were analyzed by reversed-phase HPLC using a C8 column with a mobile phase consisting of acetonitrile-water-trifluoroacetic acid (20:80:0.1, v/v/v). The UV absorbance of the column effluent was monitored at a wavelength of 292 nm. Linear calibration curves were obtained in the range of 0.01 to 22 micrograms/ml. Precision (< or = 4% relative standard deviation) and accuracy (< or = 5% error) were acceptable at the concentrations evaluated. Application of this method to the quantitation of bropirimine in rat plasma for a toxicokinetic/bioavailability study is reported.


Related Compounds

Related Articles:

CMV specific cytokine release assay in whole blood is optimized by combining synthetic CMV peptides and toll like receptor agonists.

2014-12-01

[J. Immunol. Methods 414 , 82-90, (2014)]

Bropirimine, an orally active anticancer agent for superficial bladder cancer.

1998-08-01

[Eur. Urol. 34(2) , 107-10, (1998)]

Current and new strategies in immunotherapy for superficial bladder cancer.

2004-09-01

[Urology 64(3) , 409-21, (2004)]

Paclitaxel, bropirimine and linomide: effect on growth inhibition in a murine prostate cancer model by different growth regulatory mechanisms.

1998-03-01

[Methods Find. Exp. Clin. Pharmacol. 20(2) , 111-4, (1998)]

Bropirimine as neoadjuvant therapy decreases residual disease and expression of markers PCNA and TGF-beta 1 in a rat orthotopic prostate adenocarcinoma.

1997-05-01

[Methods Find. Exp. Clin. Pharmacol. 19(4) , 261-7, (1997)]

More Articles...